View Clinical Trial (Medical Research Study)
The Effect of Weight Loss on Bone in Men - NCT00472745-08901(Clinical Trial 169888)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
New Brunswick |
|
State:
|
|
NJ |
| Zip Code: |
|
08901 |
| Conditions: |
|
Weight Loss - Bone Density |
| Purpose: |
|
The purpose of this study is to determine the effect of weight loss on bone health in men.
|
| Study summary: |
|
This pilot study of the effect of weight loss on bone health in men is being undertaken in
conjunction with studies of the effect of weight loss on bone health in women for comparison
purposes. See NCT00473031, NCT00472680, and NCT00472654. This information is important for
determining optimal nutrient requirements during weight loss.
Participants will be recruited for both weight loss and weight maintenance. All participants
will be asked to take a daily vitamin/mineral supplement and, depending on their usual food
intake, they may be asked to take a calcium tablet to meet the recommended intake throughout
the study period. Weight loss participants will attend regular counseling sessions (about 45
minutes each) with a dietitian for approximately 6 months; they will be asked to attend 6
sessions but will be given the opportunity to attend 13 sessions. Body composition will be
measured by a dual-energy x-ray absorptiometry (DXA) machine, ultrasound, and peripheral
quantitative computer tomography (pQCT) before and after 6 months of weight loss. Bone,
mineral, protein and lipid markers, and hormones that influence bones will also be measured. |
| Criteria: |
|
Inclusion Criteria:
- Obese or overweight
- Must live in the geographic vicinity of Rutgers University
Exclusion Criteria:
- Currently on any medication known to influence calcium or bone metabolism, including
HRT, or with evidence of diseases known to influence calcium metabolism (i.e.
metabolic bone disease, hyperparathyroidism, untreated thyroid disease, significant
immune, hepatic, or renal disease, significant cardiac disease [i.e., heart attack or
stroke in the past 6 months., abnormal EKG], active malignancy or cancer therapy
within the past year)
- History of kidney stones
- Weight gain or weight loss (5% of body wt) within 3 months prior to recruitment
- Participation in other investigational studies during the 12-month study period
- Usually have a very high or low intake of calcium (more than 1500 or less than 500 mg
per day) |
|
|
|
| Study is available at: |
|
Rutgers University
New Brunswick, NJ 08901
United States
Primary Contact:
Sue Shapses, PhD, RD
Email: shapses@aesop.rutgers.edu
Phone: 732-932-9403 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|